- Home
- GORV vs GBIO Comparison
GORV vs GBIO Comparison
Compare GORV & GBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GORV
- GBIO
- Stock Information
- Founded
- GORV 1976
- GBIO 2016
- Country
- GORV United States
- GBIO United States
- Employees
- GORV N/A
- GBIO N/A
- Industry
- GORV Retail-Auto Dealers and Gas Stations
- GBIO Biotechnology: Pharmaceutical Preparations
- Sector
- GORV Consumer Discretionary
- GBIO Health Care
- Exchange
- GORV Nasdaq
- GBIO Nasdaq
- Market Cap
- GORV 25.3M
- GBIO 29.2M
- IPO Year
- GORV 2015
- GBIO 2020
- Fundamental
- Price
- GORV $6.64
- GBIO $0.52
- Analyst Decision
- GORV Hold
- GBIO Strong Buy
- Analyst Count
- GORV 2
- GBIO 4
- Target Price
- GORV $2.00
- GBIO $7.33
- AVG Volume (30 Days)
- GORV 59.0K
- GBIO 1.8M
- Earning Date
- GORV 08-15-2025
- GBIO 08-06-2025
- Dividend Yield
- GORV N/A
- GBIO N/A
- EPS Growth
- GORV N/A
- GBIO N/A
- EPS
- GORV N/A
- GBIO N/A
- Revenue
- GORV $767,257,000.00
- GBIO $24,556,000.00
- Revenue This Year
- GORV $15.65
- GBIO N/A
- Revenue Next Year
- GORV $20.54
- GBIO N/A
- P/E Ratio
- GORV N/A
- GBIO N/A
- Revenue Growth
- GORV N/A
- GBIO 146.47
- 52 Week Low
- GORV $3.95
- GBIO $0.30
- 52 Week High
- GORV $106.20
- GBIO $3.65
- Technical
- Relative Strength Index (RSI)
- GORV 43.45
- GBIO 66.42
- Support Level
- GORV $6.49
- GBIO $0.32
- Resistance Level
- GORV $8.15
- GBIO $0.59
- Average True Range (ATR)
- GORV 0.79
- GBIO 0.05
- MACD
- GORV -0.05
- GBIO 0.02
- Stochastic Oscillator
- GORV 17.04
- GBIO 76.34
About GORV Lazydays Holdings Inc.
Lazydays Holdings Inc operates recreational vehicle dealerships. It provides products and services for RV owners and outdoor enthusiasts. The company generates revenue by providing a full spectrum of RV products: New and pre-owned RV sales, RV parts and services, financing and insurance products, third-party protection plans, after-market parts and accessories, and RV camping facilities.
About GBIO Generation Bio Co.
Generation Bio Co is a genetics medicine company focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina-related diseases. It is developing two distinct and complementary platforms that It believes will enable highly differentiated therapeutic applications. Its first platform is a potent, highly selective ctLNP delivery system for nucleic acids, which is designed to avoid off-target clearance by the liver and spleen, enabling ctLNPs to persist in systemic circulation and allowing for highly selective and potent ligand-driven targeting to specific tissues and cell types. Its second platform is its novel iqDNA, which is an optimized variant of its ceDNA.